Table 4.
Multivariate analysis of variables associated with in-hospital mortality in patients with NSTEMI
| Variables | Survivors (n = 166) | Non-survivors (n = 72) | P value | AOR (95% CI) |
|---|---|---|---|---|
| Age ≥ 65y, n (%) | 86 (51.8) | 64 (88.9) | 0.039 | 2.753 (1.053–7.199) |
| Male, n (%) | 115 (69.3) | 38 (52.8) | 0.225 | 0.604 (0.267–1.365) |
| DM, n (%) | 43 (25.9) | 38 (52.8) | 0.163 | 1.786 (0.790–4.038) |
| Smoking, n (%) | 100 (60.2) | 38 (52.8) | 0.123 | 1.920 (0.838–4.403) |
| FPG ≥ 6.1 mmol/L, n (%) | 64 (38.6) | 51 (70.8) | < 0.001 | 3.823 (1.820–7.808) |
| TG ≥ 1.8 mmol/L, n (%) | 60 (36.1) | 19 (26.4) | 0.886 | 1.065 (0.452–2.506) |
| TC ≥ 6.6 mmol/L, n (%) | 11 (6.6) | 7 (9.7) | 0.617 | 1.431 (0.351–5.835) |
| AST ≥ 2ULN, n (%) | 53 (31.9) | 37 (51.4) | 0.277 | 1.681 (0.659–4.286) |
| ALT ≥ 2 ULN, n (%) | 13 (7.8) | 19 (26.4) | 0.014 | 3.698 (1.302–10.500) |
| GGT ≥ 2 ULN, n (%) | 17 (10.2) | 11 (15.3) | 0.076 | 0.280 (0.069–1.143) |
| DD ≥ 400 ng/mL, n (%) | 43 (25.9) | 50 (69.4) | 0.003 | 3.053 (0.471–6.334) |
| Tn I ≥ 2.5 ng/mL, n (%) | 53 (31.9) | 28 (38.9) | 0.712 | 0.854 (0.371–1.969) |
| Fib ≥ 3.5 g/L, n (%) | 68 (41.0) | 43 (59.7) | 0.612 | 1.210 (1.578–2.535) |
| eGFR < 90 mL/min/1.73 m2, n (%) | 52 (31.3) | 57 (79.2) | < 0.001 | 4.063 (1.890–8.737) |
Age, sex, DM, smoking history, FPG, TC, triglycerides, AST, ALT, GGT, Tn I, D-dimer, fibrinogen, and eGFR were included in the multivariate logistic regression analysis
ALT, alanine aminotransferase; AOR, adjusted odds ratio; AST, aspartate aminotransferase; CI, confidence interval; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; GGT, γ-glutamyl transpeptidase; NSTEMI, non–ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; T-Bil, total bilirubin; TC, total cholesterol; Tn I, cardiac troponin I; Fib, fibrinogen; TG, triglycerides; DD, D-dimer; ULN, upper limit of normal